Market Research Logo

Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review

Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus’ pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company also offers training workshops and provides consulting services. It distributes its products and offers services in Australia, China, Europe, India, Japan, North America, New Zealand, South America, Singapore, and Taiwan. Simulations Plus is headquartered in Lancaster, California, the US.

Simulations Plus Inc Key Recent Developments

Sep 05,2018: Simulations Plus Extends Funded Research Collaboration with the FDA
Jul 23,2018: Simulations Plus subsidiary DILIsym awarded grant for up to $1.7 Million for model development
Jul 18,2018: Simulations Plus enters funded research collaboration with Large European Consortium
Jul 10,2018: Simulations Plus Reports Third Quarter FY2018 Financial Results
Jul 03,2018: Company Profile for Simulations Plus

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Simulations Plus Inc - Key Facts
Simulations Plus Inc - Key Employees
Simulations Plus Inc - Key Employee Biographies
Simulations Plus Inc - Key Operational Employees
Simulations Plus Inc - Major Products and Services
Simulations Plus Inc - History
Simulations Plus Inc - Company Statement
Simulations Plus Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Simulations Plus Inc - Business Description
Business Segment: Cognigen Corporation
Overview
Performance
Business Segment: DILIsym Services Inc
Overview
Performance
Business Segment: Simulations Plus Inc
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: South America
Performance
R&D Overview
Simulations Plus Inc - Corporate Strategy
Simulations Plus Inc - SWOT Analysis
SWOT Analysis - Overview
Simulations Plus Inc - Strengths
Simulations Plus Inc - Weaknesses
Simulations Plus Inc - Opportunities
Simulations Plus Inc - Threats
Simulations Plus Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Simulations Plus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 05, 2018: Simulations Plus Extends Funded Research Collaboration with the FDA
Jul 23, 2018: Simulations Plus subsidiary DILIsym awarded grant for up to $1.7 Million for model development
Jul 18, 2018: Simulations Plus enters funded research collaboration with Large European Consortium
Jul 10, 2018: Simulations Plus Reports Third Quarter FY2018 Financial Results
Jul 03, 2018: Company Profile for Simulations Plus
Jun 28, 2018: Simulations Plus Releases ADMET Predictor Version 9
Apr 09, 2018: Simulations Plus Reports Record Second Quarter FY2018 Revenue
Feb 01, 2018: Simulations Plus Launches Version 2.0 of PKPlus
Jan 09, 2018: Simulations Plus Reports First Quarter FY2018 Financial Results
Nov 30, 2017: Simulations Plus Releases ADMET Predictor Version 8.5
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Simulations Plus Inc, Key Facts
Simulations Plus Inc, Key Employees
Simulations Plus Inc, Key Employee Biographies
Simulations Plus Inc, Key Operational Employees
Simulations Plus Inc, Major Products and Services
Simulations Plus Inc, History
Simulations Plus Inc, Other Locations
Simulations Plus Inc, Subsidiaries
Simulations Plus Inc, Key Competitors
Simulations Plus Inc, Ratios based on current share price
Simulations Plus Inc, Annual Ratios
Simulations Plus Inc, Annual Ratios (Cont...1)
Simulations Plus Inc, Annual Ratios (Cont...2)
Simulations Plus Inc, Interim Ratios
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Simulations Plus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Simulations Plus Inc, Performance Chart (2014 - 2018)
Simulations Plus Inc, Ratio Charts
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report